Chemokine Receptor Type 4 Interaction [EPC] - N0000193866

Pharmacologic Class Information

Pharmacologic Code N0000193866
Pharmacologic Name Chemokine Receptor Type 4 Interaction
Pharmacologic Uses
  • CC chemokine receptor type 4 (CCR4)-directed monoclonal antibody
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Chemokine Receptor Type 4 Interaction

The table contains 1 products whose active ingredient are classified under the same pharmacologic class Chemokine Receptor Type 4 Interaction [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
42747-761Poteligeo Non-Proprietary Name: Mogamulizumab-kpkcInjectionIntravenousKyowa Kirin, Inc.ACTIVE